You’ve tried minoxidil. You’ve been patient — twelve months, maybe longer — and your hair is still thinning. Or perhaps you’ve been told your hair loss is “hormonal” but nobody has offered you a treatment that actually targets the hormones responsible.
Spironolactone is an anti-androgen medicine sometimes prescribed off-label for hair loss in women. It works differently from minoxidil: rather than stimulating growth, it blocks the effect of androgens on the follicle. It is mainly considered where hair loss has a hormonal component, such as female pattern hair loss or PCOS-related thinning. This guide explains how it works, the evidence, side effects and the monitoring it needs.
Spironolactone is only prescribed after a consultation, and it needs regular monitoring. It requires blood monitoring and must not be taken during pregnancy — but for the right candidate, it addresses the root hormonal driver that other treatments leave untouched.
Why Most Women Can’t Access Spironolactone for Hair Loss
Spironolactone has been available since the 1960s. It’s inexpensive, off-patent, and well understood — yet most women with hormonal hair loss have never been offered it.
Spironolactone is available on the NHS, but because it’s off-label for hair loss and needs monitoring, many GPs prefer not to prescribe it for this purpose.
It’s worth seeing a doctor who can assess whether your hair loss has a hormonal component and monitor treatment properly.
Whoever prescribes it, the essentials are the same: confirming the diagnosis, checking it is safe for you, and regular monitoring.
How Spironolactone Works for Hair Loss
The hormone behind most women’s pattern hair loss is DHT — dihydrotestosterone. It binds to receptors in genetically sensitive hair follicles, triggering miniaturisation: each growth cycle, the follicle produces a thinner, shorter hair until eventually it stops producing visible hair altogether.
Spironolactone interrupts this in two ways. It blocks androgen receptors in hair follicles, preventing DHT from binding. And it reduces circulating androgen production, lowering the overall hormonal load on vulnerable follicles.
This is fundamentally different from how minoxidil works. Minoxidil is a vasodilator — it increases blood flow to follicles and extends the active growth phase. Effective, but it doesn’t touch the hormonal cause. If DHT is driving your follicles to shrink, minoxidil encourages growth while the damage continues underneath.
That’s exactly why the two are often prescribed together. Spironolactone stops the damage. Minoxidil promotes recovery. Different tools for different parts of the same problem.
For women with PCOS specifically, there’s another dimension. Because spironolactone blocks androgens systemically, it can simultaneously reduce hormonal acne and unwanted facial or body hair — hirsutism — which are driven by the same imbalance. One medication addressing three symptoms is why it’s considered particularly valuable for polycystic ovary syndrome.
Who Benefits Most from Spironolactone?
Spironolactone is mainly considered where hair loss has a hormonal driver — and the common thread across all candidates is androgens playing a role in thinning.
The most common use is in female pattern hair loss where thinning follows the classic diffuse pattern across the crown and parting. If blood tests show elevated androgens, or your pattern and family history suggest androgen sensitivity, spironolactone addresses the underlying mechanism that minoxidil alone doesn’t reach.
In PCOS, scalp thinning, acne and excess facial hair can share the same androgen pathway, which is why spironolactone is sometimes considered in PCOS-related hair loss.
Perimenopausal and menopausal hair loss responds well when androgens are part of the picture. As oestrogen declines, the relative influence of circulating androgens increases, and follicles that were previously protected become vulnerable.
Women who haven’t responded to minoxidil alone are strong candidates. If you’ve used topical minoxidil or oral minoxidil consistently without sufficient improvement, the missing piece may be hormonal.
Spironolactone is not suitable for pregnant women or those planning pregnancy — it risks feminisation of a male foetus. Reliable contraception is non-negotiable for pre-menopausal women. It’s also contraindicated in women with kidney disease, hyperkalaemia, or Addison’s disease, and requires careful assessment alongside ACE inhibitors, ARBs, or potassium-sparing diuretics. You will need regular blood tests whilst you are on the medication.
cta_secondary
Clinical Evidence
Spironolactone for hair loss has no marketing budget — it’s generic and off-patent. But the evidence is substantial and consistent.
Famenini et al. (2015) found that 75% of women with female pattern hair loss showed improvement on spironolactone. Burns and Sinclair (2005) demonstrated that high-dose spironolactone (200mg) matched cyproterone acetate, a more potent anti-androgen with a heavier side-effect profile.
A 79-patient retrospective study found that women with moderate to severe hair loss achieved nearly a full grade of improvement — but the crucial detail was timing. Two-thirds saw their best results at twelve months or beyond. It takes time, and results vary.
Some studies have looked at spironolactone combined with minoxidil, as they work on different mechanisms. Evidence comes mainly from small and observational studies.
Spironolactone + Minoxidil — The Combination Approach
Whether a combination is appropriate is a prescribing decision made after assessment.
Where more than one treatment is used, they should be monitored together.
Spironolactone with topical minoxidil is the most common starting combination. Spironolactone with oral minoxidil suits women who can’t tolerate topical application or whose follicles lack the enzyme to activate it. Spironolactone with certain oral contraceptive formulations — particularly drospirenone-containing pills — adds an additional anti-androgenic layer while providing essential contraception.
Dosage, Timeline, and Side Effects
Treatment typically starts at 25–50mg daily, titrated upward to 50–200mg based on your response, tolerance, blood results, and other medications. The dose depends on your age, blood results and other medicines.
Any change takes months to judge. Reduced shedding may be the first change, and density is usually assessed at six to twelve months. Results vary, and it doesn’t work for everyone.
Breast tenderness is the most common side effect, usually settling within the first few months. Menstrual irregularities in pre-menopausal women are often resolved by combining with the oral contraceptive pill. Dizziness when standing quickly is most noticeable early in treatment and typically improves. Increased urination is expected — spironolactone is a diuretic.
Elevated potassium is the side effect that requires monitoring and is why blood tests are part of the protocol. Avoid excessive quantities of high-potassium foods — bananas, oranges, spinach, potatoes — though normal dietary amounts are fine. Fatigue and reduced libido are uncommon and usually dose-related.
Blood pressure is checked before starting. Baseline bloods assess potassium and kidney function. Repeat tests at three-six months, then annually, with more frequent checks if needed.
How Prescribing Decisions Are Made
Your consultation begins with a full medical history, trichoscopy assessment, and blood test review (most patients bring their NHS results however we have our own hair-specific panel — checking androgen levels, potassium, kidney function, and nutritional factors which can be arranged if needed). Spironolactone is only considered after confirming a hormonal component to your hair loss.
Dosing is personalised and titrated gradually. If you’re pre-menopausal, the contraception discussion happens before prescribing begins — Dr Amy discusses options including formulations that complement spironolactone’s anti-androgenic effects.
Ongoing monitoring tracks your response through clinical photography and trichoscopy at each follow-up, reviews blood results, and adjusts the plan.
You won’t be handed a prescription and left to manage alone. The prescribing is the beginning of a treatment relationship, not a transaction.
Frequently Asked Question
Spironolactone is available on the NHS, but it is not always prescribed for hair loss there, because it’s off-label for this use and needs monitoring. A doctor experienced in hair loss can assess whether it’s appropriate and monitor it.
They work in different ways. Spironolactone blocks the effect of androgens on the follicle, while minoxidil acts on blood flow and the growth phase. Read more about oral minoxidil and topical minoxidil.
Often, yes. Spironolactone must not be taken in pregnancy, so reliable contraception is important. Your doctor will check that your contraception and any other medicines are compatible.
It manages rather than cures hormonal hair loss. If you stop, the androgenic influence on your follicles resumes and thinning may gradually return. Treatment is reviewed regularly.
Its anti-androgen effect can reduce unwanted facial and body hair growth (hirsutism) in some women, which is why it is sometimes considered in PCOS, where both share the same hormonal driver.
Reduced shedding may appear within one to three months, and changes in density are usually judged at six to twelve months. Results vary.
Spironolactone can raise potassium levels, so avoid excessive consumption of high-potassium foods — bananas, oranges, spinach, and potatoes in large quantities. Your blood potassium will be monitored regularly. Normal amounts of these foods are fine; it’s the excessive intake that matters.
Speaking to a doctor
If your hair loss may have a hormonal component, such as female pattern hair loss, PCOS or menopausal thinning, a doctor can assess whether spironolactone is suitable for you, or whether another approach would suit you better.
Any prescription medicine for hair loss is prescribed only after a consultation, once a doctor has assessed whether it is suitable for you. A doctor can talk you through all of your options, including not starting treatment.
